Adamec, I., Rogić, D., Penz, M. G., Braun, C. & Habek, M. (2022). Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab. Journal of Neuroimmunology, 362.. doi: 10.1016/j.jneuroim.2021.577788
Adamec, Ivan, et al. "Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab." Journal of Neuroimmunology, vol. 362, 2022. https://doi.org/10.1016/j.jneuroim.2021.577788
Adamec, Ivan, Dunja Rogić, Monika Gabriele Penz, Carola Braun and Mario Habek. "Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab." Journal of Neuroimmunology 362 (2022). https://doi.org/10.1016/j.jneuroim.2021.577788
Adamec, I., et al. (2022) 'Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab', Journal of Neuroimmunology, 362. doi: 10.1016/j.jneuroim.2021.577788
Adamec I, Rogić D, Penz MG, Braun C, Habek M. Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab. Journal of Neuroimmunology [Internet]. 2022 January 15 [cited 2024 October 04];362. doi: 10.1016/j.jneuroim.2021.577788
I. Adamec, D. Rogić, M. G. Penz, C. Braun and M. Habek, "Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab", Journal of Neuroimmunology, vol. 362, January 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:570068. [Accessed: 04 October 2024]